Schonfeld Strategic Advisors LLC Chembio Diagnostics, Inc. Transaction History

Schonfeld Strategic Advisors LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 16, 2021	SELL	$2.06 - $5.34 $22,248 - $57,672	-10,800 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$2.88 - $5.64 $31,104 - $60,912	10,800 New	10,800 $32,000
Q1 2019 May 15, 2019	SELL	$5.32 - $7.18 $133,000 - $179,500	-25,000 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$4.95 - $10.5 $123,750 - $262,500	25,000 New	25,000 $142,000

Ticker CEMI
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 30,224,600
Description
Chembio Diagnostics, Inc., together with its subsidiaries, develops, manufactures, and commercializes point-of-care (POC) diagnostic tests that are used to detect or diagnose diseases. The company offers tests for COVID-19, HIV and Syphilis, and Zika virus. It also develops tests for malaria, dengue, chikungunya, Chagas, ebola, leishmaniasis, la...

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.